Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Sophie Michallet

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Current Opinion in Oncology|July 18, 2014
Bruton's tyrosine kinase inhibitors: lessons learned from bench-to-bedside (first) studiesLoic Ysebaert, Anne-Sophie Michallet
The Lancet. Haematology|April 1, 2016
B-cell receptor stereotypy and chronic lymphocytic leukaemiaAnne-Sophie Michallet, Bertrand Coiffier
La Revue Du Praticien|December 5, 2018
Hélène Lequeu, Anne-Sophie Michallet
Blood Reviews|July 16, 2008
Recent developments in the treatment of aggressive non-Hodgkin lymphomaAnne-Sophie Michallet, Bertrand Coiffier
Supportive Cancer Therapy|July 17, 2008
Optimizing management of tumor lysis syndrome in adults with hematologic malignanciesAnne-Sophie Michallet, Sophie Tartas, Bertrand Coiffier
Current Opinion in Oncology|July 9, 2015
Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapiesLoïc Ysebaert, Pierre Feugier, Anne-Sophie Michallet
Bulletin Du Cancer|November 12, 2003
[Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy]Anne-Sophie Michallet, F Nicolini, Mauricette Michallet
Current Opinion in Oncology|July 5, 2012
Maintenance therapy in diffuse large B-cell lymphomaAnne-Sophie Michallet, Laure Lebras, Bertrand Coiffier
Current Opinion in Oncology|July 8, 2011
Maintenance therapy in follicular lymphomaAnne-Sophie Michallet, Bertrand Coiffier, Gilles Salles
Current Opinion in Oncology|August 5, 2010
Role of early PET in the management of diffuse large B-cell lymphomaAnne-Sophie Michallet, Judith Trotman, Christelle Tychyj-Pinel
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Current Opinion in Oncology|July 18, 2014
Bruton's tyrosine kinase inhibitors: lessons learned from bench-to-bedside (first) studiesLoic Ysebaert, Anne-Sophie Michallet
The Lancet. Haematology|April 1, 2016
B-cell receptor stereotypy and chronic lymphocytic leukaemiaAnne-Sophie Michallet, Bertrand Coiffier
La Revue Du Praticien|December 5, 2018
Hélène Lequeu, Anne-Sophie Michallet
Blood Reviews|July 16, 2008
Recent developments in the treatment of aggressive non-Hodgkin lymphomaAnne-Sophie Michallet, Bertrand Coiffier
Supportive Cancer Therapy|July 17, 2008
Optimizing management of tumor lysis syndrome in adults with hematologic malignanciesAnne-Sophie Michallet, Sophie Tartas, Bertrand Coiffier
Current Opinion in Oncology|July 9, 2015
Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapiesLoïc Ysebaert, Pierre Feugier, Anne-Sophie Michallet
Bulletin Du Cancer|November 12, 2003
[Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy]Anne-Sophie Michallet, F Nicolini, Mauricette Michallet
Current Opinion in Oncology|July 5, 2012
Maintenance therapy in diffuse large B-cell lymphomaAnne-Sophie Michallet, Laure Lebras, Bertrand Coiffier
Current Opinion in Oncology|July 8, 2011
Maintenance therapy in follicular lymphomaAnne-Sophie Michallet, Bertrand Coiffier, Gilles Salles
Current Opinion in Oncology|August 5, 2010
Role of early PET in the management of diffuse large B-cell lymphomaAnne-Sophie Michallet, Judith Trotman, Christelle Tychyj-Pinel
Pageof 10